期刊文献+

shRNA沉寂HK-Ⅱ表达对胃癌SGC7901细胞增殖、凋亡的影响 被引量:2

shRNA-mediated silencing of hexokinase Ⅱ inhibits proliferation but promotes apoptosis in SGC7901 cells
下载PDF
导出
摘要 目的:观察shRNA沉寂HK-Ⅱ基因的表达对胃癌细胞株SGC7901细胞增殖、凋亡的影响,初步评价HK-Ⅱ基因治疗胃癌的应用前景.方法:取胃癌细胞株SGC7901及胃上皮细胞株GES-1细胞为研究对象,将每株细胞分别分成5组(A:干扰组;B:阳性对照组;C:阴性对照组;D:脂质体组;E:空白对照组).用shRNA沉寂胃癌细胞株SGC7901及胃上皮细胞株GES-1细胞中HK-Ⅱ的表达.用逆转录-聚合酶链反应(RT-PCR)检测转染shRNA后每株细胞中各组HK-ⅡmRNA的表达变化;分别用MTT及流式细胞仪检测转染后细胞增殖、凋亡的变化.结果:HK-ⅡmRNA在胃癌细胞株SGC7901细胞中的表达明显高于胃上皮细胞株GES-1细胞(t=12.119,P<0.01),HK-ⅡshRNA可以明显抑制两株细胞中HK-Ⅱ的表达(P<0.01).沉寂HK-Ⅱ的表达可抑制SGC7901细胞的增殖(F=159.811,P<0.01),并促进其凋亡(χ2=21.324,P<0.01);但对胃上皮细胞增殖(F=0.704,P=0.592)及凋亡(χ2=1.007,P=0.909)无明显影响.结论:沉寂HK-Ⅱ表达可以抑制胃癌细胞株SGC7901的增殖,促进其凋亡;但对胃上皮细胞株GES-1无明显影响.HK-Ⅱ可能成为胃癌治疗的一个靶点. AIM:To observe the changes in cell proliferation and apoptosis in gastric cancer cell line SGC7901 after silencing the hexokinase II (HK-II) gene with an HK-II-specific shRNA, and to assess the potential application of HK-II-targeted gene therapy for gastric cancer.METHODS:Gastric cancer cell line SGC7901 and gastric epithelial cell line GES-1 were used in this study.Both SGC7901 cells and GES-1 cells were divided into 5 groups:HK-II shRNA group, positive control group, negative control group, empty liposome group, and blank control group.After transfection of HK-II-specific shRNA into SGC7901 and GES-1 cells, the change in the expression of HK-II mRNA was detected by reverse transcription-polymerase chain reaction (RT-PCR), and the changes in cell proliferation and apoptosis were assessed by MTT assay and flow cytometry, respectively.RESULTS:The expression level of HK-II mRNA in SGC7901 cells was significantly higher than that in GES-1 cells (t=12.119, P0.01).The expression of HK-II mRNA was obviously silenced after transfection of HK-II-specific shRNA (P0.01).HK-II knockdown could significantly inhibit proliferation (F=159.811, P0.01) and promote apoptosis (χ2=21.324, P0.01) in SGC7901 cells, but had no significant effect on proliferation and apoptosis in GES-1 cells (F=0.704, P=0.592; χ2=1.007, P=0.909).CONCLUSION:HK-II knockdown significantly inhibits proliferation and promotes apoptosis in SGC7901 cells, but has no significant impact in GES-1 cells.HK-II may be a potential target for the treatment of gastric cancer.
出处 《世界华人消化杂志》 CAS 北大核心 2010年第18期1860-1866,共7页 World Chinese Journal of Digestology
基金 江西省教育厅课题基金资助项目 No.赣教技字2007-75~~
关键词 己糖激酶 短发夹状RNA SGC7901 GES-1 Hexokinase Short-hairpin RNA SGC7901 GES-1
  • 相关文献

参考文献20

  • 1Mathupala SP,Rempel A,Pedersen PL.Glucose catabolism in cancer cells:identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions.J Biol Chem 2001; 276:43407-43412.
  • 2Ko YH,Pedersen PL,Geschwind JF.Glucose catabolism in the rabbit VX2 tumor model for liver cancer:characterization and targeting hexokinase.Cancer Lett 2001; 173:83-91.
  • 3Brown RS,Goodman TM,Zasadny KR,Greenson JK,Wahl RL.Expression of hexokinase II and Glut-1 in untreated human breast cancer.Nucl Med Biol 2002; 29:443-453.
  • 4Mathupala SP,Rempel A,Pedersen PL.Glucose catabolism in cancer cells.Isolation,sequence,and activity of the promoter for type II hexokinase.J Biol Chem 1995; 270:16918-16925.
  • 5Rempel A,Mathupala SP,Perdersen PL.Glucose catabolism in cancer cells:regulation of the Type II hexokinase promoter by glucose and cyclic AMP.FEBS Lett 1996; 385:233-237.
  • 6王宁,陈凛,赵向阳.干细胞与胃癌关系的研究进展[J].世界华人消化杂志,2006,14(17):1710-1713. 被引量:4
  • 7Gatenby RA,Gillies RJ.Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4:891-899.
  • 8Shinohara Y,Ichihara J,Terada H.Remarkably enhanced expression of the type II hexokinase in rat hepatoma cell line AH130.FEBS Lett 1991; 291:55-57.
  • 9Rempel A,Bannasch P,Mayer D.Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages.Biochim Biophys Acta 1994;1219:660-668.
  • 10Johansson T,Berrez JM,Nelson BD.Evidence that transcription of the hexokinase gene is increased in a rapidly growing rat hepatoma.Biochem Biophys Res Commun 1985; 133:608-613.

二级参考文献29

  • 1Katoh Y,Katoh M.Hedgehog signaling pathway and gastric cancer.Cancer Biol Ther 2005; 4:1050-1054
  • 2Tai MH,Chang CC,Kiupel M,Webster JD,Olson LK,Trosko JE.Oct4 expression in adult human stem cells:evidence in support of the stem cell theory of carcinogenesis.Carcinogenesis 2005; 26:495-502
  • 3Sell S.Stem cell origin of cancer and differentiation therapy.Crit Rev Oncol Hematol 2004; 51:1-28
  • 4Alison MR,Poulsom R,Forbes S,Wright NA.An introduction to stem cells.J Pathol 2002; 197:419-423
  • 5Caussinus E,Gonzalez C.Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster.Nat Genet 2005; 37:1125-1129
  • 6Huang J,Behrens C,Wistuba Ⅱ,Gazdar AF,Jagirdar J.Clonality of combined tumors.Arch Pathol Lab Med 2002; 126:437-441
  • 7Bjerkvig R,Tysnes BB,Aboody KS,Najbauer J,Terzis AJ.Opinion:the origin of the cancer stem cell:current controversies and new insights.Nat Rev Cancer 2005; 5:899-904
  • 8Bonnet D,Dick JE.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.Nat Med 1997; 3:730-737
  • 9Al-Hajj M,Wicha MS,Benito-Hernandez A,Morrison SJ,Clarke MF.Prospective identification of tumorigenic breast cancer cells.Proc Natl Acad Sci USA 2003; 100:3983-3988
  • 10Modlin IM,Kidd M,Lye KD,Wright NA.Gastric stem cells:an update.Keio J Med 2003; 52:134-137

共引文献3

同被引文献18

  • 1彭秋平,梁后杰,周琪,周进明,傅晓岚,钟大平.己糖激酶-Ⅱ基因在人结肠癌细胞中的表达及其治疗意义[J].中华医学杂志,2007,87(15):1058-1062. 被引量:12
  • 2Gatenby RA, Gillies RJ.Why do cancers have high aerobic glycolysis Nat Rev Cancer,2004,4(11):891-899.
  • 3Christotk HR,Vander Heiden MG,Wu N,et al .Pyruvate kinase M2 is a hosphotyrosine-binding protein [J]. Nature, 2008,452(7184): 181- 186.
  • 4KJ.Kwon-Chung,et al.Cryptococcosis:clinical and biologic aspects[J]. Med. Mycol,2000,38(1):205-213.
  • 5Geran GI, Greenberg NH, MacDonald MM, et al. Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemotherap Rep 1962, 25:1-66.
  • 6Smith TA.Mammalian hexokinases and their abnormal expression in cancer. Br J Biomed Sci, 2000,57(2): 170-178.
  • 7Robey RB,Hay N. Mitochondrial hexokinases: guardians of the mitochondria[J]. Cell Cycle, 2005,4(5): 654-658.
  • 8Shinohara Y,Ishid a T,Hino M.Characterization of porin isoforms expressed in tumor cells[J]. Eur J Biochem,2000,267(19):6067-6073.
  • 9Rempel A. Glucose Catabolism in Cancer Cells:Regulation of the T- ype II Hexokinase Promoter by Glucose and Cyclic AMP [J]. FEBS Lett, 1996,385(3):233-237.
  • 10Peng QP, Zhou Q, Liang HJ, et al.Stable RNA interference of hexokinase- II gene inhibits human colon cancer LoVo cell growth in vitro and in vivo [J]. Cancer Biology and Therapy, 2008, 7(7):1128-1135.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部